Melanoma News and Research

Latest Melanoma News and Research

Targepeutics issued new U.S patent

Targepeutics has announced the issuance of U.S. Patent No. 6,884,603 for its genetically modified, mutated Interleukin 13 (IL-13) technology platform for the treatment of malignant glioma, a brain tumor (17,500 people annually; $200 million annual market).

31 May 2005

New understanding of DNA repair processes may pave way to cancer treatments

A Burnham Institute study has found that a protein known for its role in gene regulation has another important function, that of initiating DNA repair. The study, published in the May 27th edition of Molecular Cell, points to new targets for treatment of cancer.

30 May 2005

Whole-body positron emission tomography/computed tomography scans may help physicians identify malignant cancerous tumors

A team of researchers at Johns Hopkins Medical Institutions in Baltimore, Md., reports that whole-body positron emission tomography/computed tomography (PET/CT) scans may help physicians identify new, unexpected malignant cancerous tumors in patients, according to an article in the May issue of the Society of Nuclear Medicine’s Journal of Nuclear Medicine.

29 May 2005

Sunshine makes you feel good and may also help fight cancers

Although Vitamin D, the sunshine vitamin, gets little media attention, it is, surprisingly, a good tool in the fight against cancer.

22 May 2005

Antiretroviral therapy may prevent excess risk of some cancers in people with HIV

In people infected with human immunodeficiency virus (HIV), highly active anti-retroviral therapy (HAART) may prevent most excess cases of Kaposi sarcoma and non-Hodgkin lymphoma, according to a new study in the March 16 issue of the Journal of the National Cancer Institute.

18 May 2005

Jefferson researcher’s results show promise for metastatic eye melanoma

But now, by simultaneously revving up the immune system and choking off the tumor’s oxygen supply, oncologists at Jefferson Medical College and the Kimmel Cancer Center at Thomas Jefferson University in Philadelphia may have found a better way to battle this deadly cancer.

17 May 2005

High-risk for melanoma patients no more likely to take proper precautions in the sun

Those considered high-risk for melanoma--the most dangerous form of skin cancer--are no more likely to sunbathe protected than those who are unaware of their risk, according to a new study conducted by McGill University Health Centre (MUHC) researchers.

16 May 2005

Green laser pointers can cause visible harm to the eye's retina

Mayo Clinic ophthalmologists have found commercially available Class 3A green laser pointers can cause visible harm to the eye's retina with exposures as short as 60 seconds. The findings will be published in the May issue of Archives of Ophthalmology.

9 May 2005

Critical lock and key mechanism found for the assembly of tumor blood vessels

A critical lock and key mechanism that allows the final step in the completion of new blood vessel formation has been identified by a University of California, San Diego (UCSD) School of Medicine team in research that promises to lead to a new way to halt tumor growth by cutting off the tumor blood supply.

3 May 2005

Majority of women still prefer the bronzed look over their natural skin tone

Skin care products and cosmetic therapies that promise to erase the telltale signs of sun damage are everywhere. Ironically, women who seek these treatments to improve the appearance of their skin could have avoided their fate by avoiding excessive sun exposure in the first place.

2 May 2005

Teenagers sunbake despite skin cancer knowledge

A teenager’s world is paved with warning signs. Whether the signs urge teens to avoid drinking, smoking or even tanning, the message is the same – sooner or later, the consequences of their actions will catch up with them. When it comes to tanning, teenagers know that tanning can cause skin cancer but choose to tan to “look good” anyway, according to a new survey by the American Academy of Dermatology.

2 May 2005

Increasing exposure to either natural or artificial ultraviolet (UV) light should not be recommended as a supplemental source of vitamin D

Based on data reviewed by a consensus conference convened by the American Academy of Dermatology Association to examine the relationship between sunlight, tanning booths and vitamin D, renowned medical experts agreed that increasing exposure to either natural or artificial ultraviolet (UV) light should not be recommended as a supplemental source of vitamin D.

2 May 2005

Adults are much more likely to protect their children from the sun than themselves

Adults with children or grandchildren know that protecting their little ones from the sun is essential to preventing painful sunburns. But while parents and grandparents are busy slathering kids with sunscreen and arming them with hats and protective clothing, they are not as likely to practice this same behavior when it comes to protecting themselves, according to a new survey by the American Academy of Dermatology.

2 May 2005

Shade structure grants help make it safer to have fun in the sun

With warm, sunny weather outside, no one wants to find themselves cooped up indoors, especially children. But heading outdoors without adequate sun protection can lead to a sunburn that lingers long after the outdoor fun has ended. Sunburns are known to have a cumulative effect and can lead to future skin cancers including melanoma, the deadliest form of skin cancer.

2 May 2005

Children treated for soft tissue sarcomas at greater risk of second cancers

A new study has found that although children treated for soft tissue sarcomas are surviving longer than they did in the past, they have an increased risk for second cancers, especially when initial treatment combined radiation and chemotherapy. This is according to analysis of data from the Surveillance, Epidemiology, and End Results (SEER) Program of the National Cancer Institute.

27 Apr 2005

National clinical trial examines new option for kidney cancer patients

The trial, which opened last September, offers research subjects who qualify a new, targeted therapy in addition to standard immune therapy. The drug combination is being studied in a national Phase II clinical trial led by OHSU Cancer Institute researcher Christopher Ryan, M.D., through the Southwest Oncology Group, one of the largest clinical trial cooperative groups in the United States.

27 Apr 2005

Isotopes for society

The nucleus of an atom contains protons and neutrons. However, some atoms of the same chemical element can have varying numbers of neutrons, giving so-called isotopes of that element.

27 Apr 2005

High risk of second cancers in survivors of childhood soft tissue sarcomas

Children treated for soft tissue sarcomas have a significantly higher risk of developing subsequent cancers later in life, according to a new study. The study appears in the June 1, 2005 issue of CANCER, a peer-reviewed journal of the American Cancer Society, and indicates children treated with combined chemotherapy and radiation therapy, in particular, had greater risks of developing a new malignancy.

25 Apr 2005

Nanoparticles reveal tiny cancerous tumors

Specially designed nanoparticles can reveal tiny cancerous tumors that are invisible by ordinary means of detection, according to a study by researchers at Washington University School of Medicine in St. Louis.

22 Apr 2005

Clinical study of MDX-010/MDX-1379 combination shows durable responses in patients with metastatic melanoma

Medarex, Inc. and Bristol-Myers Squibb Company announced today that complete or partial responses in seven of 56 patients with metastatic melanoma showed durability ranging from four months to the longest still ongoing at over 34 months, with five of the seven responses ongoing for more than two years.

20 Apr 2005